[Investigation of adverse events and the continuance rate of silodosin in all patients who received silodosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples